AMAG Pharmaceuticals files automatic shelf to sell debt, stock

By Susanna Moon

Chicago, Jan. 19 - AMAG Pharmaceuticals, Inc. registered to sell an unspecified amount of securities in an S-3ASR filing with the Securities and Exchange Commission.

Covered by the automatic shelf filing are common stock, preferred stock, debt securities and warrants. Securities may be issued as convertibles.

Proceeds will be used for general corporate purposes.

AMAG is a biopharmaceutical company based in Cambridge, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.